Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$164,572
+$40,821 QoQ
Shares Held
654
+14.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#3,981
of 4,150 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hughes Financial Services, LLC holds $1,452,653 across 13 Drug Manufacturers - General names. ABBV ranks #3 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
443 | $531,347 | |
| 2 | JNJ |
Johnson & Johnson
|
1,052 | $267,176 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
654 | $164,572 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,162 | $149,317 | |
| 5 | AMGN |
Amgen Inc
|
401 | $145,210 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,874 | $107,979 | |
| 7 | PFE |
Pfizer Inc
|
1,324 | $31,881 | |
| 8 | AZN |
Astrazeneca PLC
|
95 | $18,013 |
All Filings in ABBV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $164,572 | 654 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $123,751 | 569 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $127,040 | 556 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $128,736 | 556 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $110,815 | 597 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $116,493 | 556 | Shares | Sole | 2025-05-01 | |
| No filing history on record for this holder in this stock. | ||||||